Cargando…

Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay

The clinical and epidemiologic management of the SARS-CoV-2 pandemic is critically dependent on molecular assays with short turn-around time. We validated the novel Xpert Xpress SARS-CoV-2 assay using a commercial nucleic acid testing (Roche Cobas 6800). We found an excellent concordance over a rang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldenberger, Daniel, Leuzinger, Karoline, Sogaard, Kirstine K., Gosert, Rainer, Roloff, Tim, Naegele, Klaudia, Cuénod, Aline, Mari, Alfredo, Seth-Smith, Helena, Rentsch, Katharina, Hinić, Vladimira, Hirsch, Hans H., Egli, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351036/ https://www.ncbi.nlm.nih.gov/pubmed/32659240 http://dx.doi.org/10.1016/j.jviromet.2020.113925

Ejemplares similares

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020)

Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen
por: Vaz, Sara Nunes, et al.
Publicado: (2021)

Diagnostic challenges within the Bacillus cereus-group: finding the beast without teeth
por: Muigg, Veronika, et al.
Publicado: (2022)

Cutibacterium modestum and “Propionibacterium humerusii” represent the same species that is commonly misidentified as Cutibacterium acnes
por: Goldenberger, Daniel, et al.
Publicado: (2021)

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

First case of IMP-15-producing Pseudomonas aeruginosa in Switzerland: Challenging laboratory diagnosis using whole genome sequencing (WGS)
por: Goldenberger, Daniel, et al.
Publicado: (2020)

Rapid Evaluation of the Xpert(®) Xpress CoV-2 plus and Xpert(®) Xpress CoV-2/Flu/RSV plus Tests
por: Noble, Lara Dominique, et al.
Publicado: (2022)

Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
por: Broder, Kari, et al.
Publicado: (2020)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants
por: Leuzinger, Karoline, et al.
Publicado: (2022)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Unexpectedly High False-Positive Rates for Haemophilus influenzae Using a Meningoencephalitis Syndromic PCR Panel in Two Tertiary Centers
por: Zanella, Marie-Céline, et al.
Publicado: (2021)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay
por: Graham, Maryza, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)

Tick-Borne Relapsing Fever Caused by Borrelia persica in Traveler to Central Asia, 2019
por: Muigg, Veronika, et al.
Publicado: (2020)

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections
por: Florea, Dragoş, et al.
Publicado: (2014)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020)

Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test for bronchoalveolar lavage
por: Phan, Tung, et al.
Publicado: (2022)

The Diagnostic Accuracy of Xpert Xpress to SARS-CoV-2: A systematic review
por: Cao, Xun-Jie, et al.
Publicado: (2022)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Prospective evaluation of GeneXpert for the diagnosis of HIV- negative pediatric TB cases
por: Giang, Do Chau, et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis
por: Cuong, Nguyen Kim, et al.
Publicado: (2021)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
por: Saeed, Muhammad, et al.
Publicado: (2020)

Diagnosing an atypical case of tuberculosis presenting as dacryocystitis: Sac biopsy and GeneXpert
por: Lokdarshi, Gautam, et al.
Publicado: (2022)

Missed opportunities for integrated testing of HIV and tuberculosis on the GeneXpert platform in Lesotho
por: Gwaza, Gamuchirai P., et al.
Publicado: (2023)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

European multicenter evaluation of Xpert® Xpress SARS‐CoV‐2/Flu/RSV test
por: Wolters, Femke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vibic58q02v8rer8178b66f1d9